Xtant Medical Holdings, Inc. (XTNT) News
Filter XTNT News Items
XTNT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest XTNT News From Around the Web
Below are the latest news stories about XTANT MEDICAL HOLDINGS INC that investors may wish to consider to help them evaluate XTNT as an investment opportunity.
Q3 2023 Xtant Medical Holdings Inc Earnings CallQ3 2023 Xtant Medical Holdings Inc Earnings Call |
Xtant Medical to Participate in Upcoming Investor ConferencesBELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that management will participate in two upcoming investor conferences: Jefferies London Healthcare Conference – November 14-16 Sean Browne, President and CEO, will present on Thursday, November 16 at 11:00 AM GMT / 6:00 AM ET and participate in 1x1 meetings with institutional |
Xtant Medical Holdings Inc (XTNT) Reports Record Q3 Revenue and Raises 2023 GuidanceXTNT Achieves 73% Year-Over-Year Revenue Growth in Q3; Net Income Reaches $9.2 Million |
Xtant Medical Announces Record Third Quarter Revenue of $25 MillionRaises 2023 Annual Revenue Guidance to $88 Million - $91 MillionBELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30, 2023. “Driven by strong organic growth of 18%, and contributions from our recent acquisitions, we achieved record third quarter revenue of |
Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023BELGRADE, Mont., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2023, before the open of the financial markets on Thursday, November 9, 2023. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a confere |
Xtant Medical Announces Acquisition of nanOss Production Operations from RTI SurgicalExpands Xtant’s Manufacturing Capabilities and Capacity to Drive Growth BELGRADE, Mont., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has acquired the nanOss production operations from RTI Surgical, Inc., a leading CDMO in regenerative medicine. Under the terms of the purchase agreement, Xtant acquired certain assets, including |
Xtant Medical Highlights Growing Product Portfolio at NASS 2023BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products at the North American Spine Society (NASS) 2023 Annual Meeting, which will be held October 18-21 at the Los Angeles Convention Center in Los Angeles, CA. “In recent years, we have dramatically expanded o |
Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics BusinessBELGRADE, Mont., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it completed the acquisition of certain assets and liabilities related to the domestic and international biologics and spinal fixation offerings of Surgalign Holdings, Inc. under a Bankruptcy Court supervised process for $5 million, plus assumed liabilities, in an all-ca |
Q2 2023 Xtant Medical Holdings Inc Earnings CallQ2 2023 Xtant Medical Holdings Inc Earnings Call |
Xtant Medical Announces Second Quarter Revenue Growth of 32%Raises 2023 Annual Revenue Guidance to $75 Million - $77 Million BELGRADE, Mont., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2023. “In the second quarter, we achieved strong revenue growth on both a sequential and annual basis driven by our core biologics and fixatio |